Today, the Wall Street Journal published an article on an NCI study regarding the costs of cancer care.
The study “estimates that medical spending on cancer hit about $125 billion last year. Assuming no changes to cancer trends except that there will be more people with the disease due to the aging population, costs will jump 27% to $158 billion in 2020.
“That increase is influenced by a projected rise in the number of prostate- and breast-cancer patients.”
The assumption that the cost of care will not change may be faulty, since new targeted therapies tend to be costly.
See full article here
See the full study here
See the model and change assumptions here